Cadent Capital Advisors’s Oracle ORCL Stock Holding History

Cadent Capital Advisors’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-719	Closed	-$202K	–	204
2025 Q3	$202K	Buy	+719	New	+$183K	0.05%	191

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cadent Capital Advisors's ORCL Position: Q4 2025 in Review

Cadent Capital Advisors sold out of Oracle (ORCL) in Q4 2025, closing a stake of 719 shares — an estimated $202K sold.

Cadent Capital Advisors first reported a position in ORCL in Q3 2025 and held it in 1 quarter. The position peaked at $202K in Q3 2025. 3,770 funds tracked by Wall St. Rank hold ORCL as of Q4 2025.

Cadent Capital Advisors reported no remaining Oracle position as of Q4 2025 after selling out during the quarter.
Cadent Capital Advisors sold 719 Oracle shares in Q4 2025, an estimated $202K.
Cadent Capital Advisors first reported a position in Oracle in Q3 2025 and held it in 1 quarter.
Cadent Capital Advisors's Oracle position peaked at $202K in Q3 2025.
3,770 funds tracked by Wall St. Rank held Oracle as of Q4 2025.

Based on Cadent Capital Advisors's 13F filing for Q4 2025, filed 13 Jan 2026.